Posted in | News | Medical Optics

Leica Microsystems Launch Slidepath Gateway App for iPhone and iPad

Leica Microsystems announces the release of the SlidePath Gateway application for iPad and iPhone, which is the latest addition to the Total Digital Pathology portfolio. SlidePath Gateway is a Digital Pathology viewing application with built-in educational content from leading institutes and pathologists. The free application is available now for download from the Apple App store.

 

 

SlidePath Gateway provides access to high quality whole slide images captured on the Leica SCN400 slide scanner, with expert review findings and content provided by contributing bodies including:

  • ASCP CheckPath Anatomical Pathology EQA Program (2006)
  • Cerviva Cervical Cytology EQA Pilot (2009)
  • NHS Breast Screening Pathology EQA Program (2010)
  • UK National Urologic Pathology EQA Program (2009)
  • UKNEQAS HER2 Breast Interpretive EQA Pilo (2011)

Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems says, “The release of the SlidePath Gateway App displays Leica Microsystems’ commitment to develop and expand its Digital Pathology portfolio. With this App we are giving everyone the opportunity to try Digital Pathology, access high resolution whole slide images and expert opinions, through a highly intuitive user interface. With the rapid adoption and acceptance of iPads and other tablet devices in hospitals and clinical settings, we see SlidePath Gateway paving the way for future adoption of Digital Pathology in routine use.”

SlidePath Gateway for the iPad puts Digital Pathology at your fingertips. Users who install the application can browse folders of images from each of the External Quality Assessment (EQA) programs, select individual cases and view, zoom and navigate around the slides. Each case includes expert pathologist assessments, which can be viewed with the slides, giving increased insight into the samples. They can also see a sample set of Leica Biosystems’ Novocastra antibody range.
Existing users of Leica Microsystems’ Digital Pathology management solution, SlidePath Digital Image Hub (DIH), who usually access their system via a standard internet browser, can now securely connect to their own DIH library of images and review them through the application.

Building on a strong reputation for providing high quality, easy-to-use systems, SlidePath Gateway demonstrates Leica’s drive to deliver cutting edge, flexible tools to the Digital Pathology market.

To get the App, go to http://itunes.apple.com/ie/app/slidepath/id444440076?mt=8&ign-mpt=uo%3D4

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Leica Microsystems GmbH. (2023, April 14). Leica Microsystems Launch Slidepath Gateway App for iPhone and iPad. AZoOptics. Retrieved on April 14, 2024 from https://www.azooptics.com/News.aspx?newsID=13982.

  • MLA

    Leica Microsystems GmbH. "Leica Microsystems Launch Slidepath Gateway App for iPhone and iPad". AZoOptics. 14 April 2024. <https://www.azooptics.com/News.aspx?newsID=13982>.

  • Chicago

    Leica Microsystems GmbH. "Leica Microsystems Launch Slidepath Gateway App for iPhone and iPad". AZoOptics. https://www.azooptics.com/News.aspx?newsID=13982. (accessed April 14, 2024).

  • Harvard

    Leica Microsystems GmbH. 2023. Leica Microsystems Launch Slidepath Gateway App for iPhone and iPad. AZoOptics, viewed 14 April 2024, https://www.azooptics.com/News.aspx?newsID=13982.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.